Total Payments
$1.7M
2024 Payments
$140,649
Companies
21
Transactions
1,665
Medicare Patients
56
Medicare Billing
$9,268
Payment Breakdown by Category
Other$1.4M (82.2%)
Travel$186,095 (11.2%)
Consulting$72,111 (4.3%)
Food & Beverage$38,583 (2.3%)
Education$450.34 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1.3M | 534 | 78.0% |
| Travel and Lodging | $186,095 | 432 | 11.2% |
| Consulting Fee | $72,111 | 24 | 4.3% |
| Honoraria | $69,893 | 36 | 4.2% |
| Food and Beverage | $38,583 | 628 | 2.3% |
| Education | $450.34 | 11 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ViiV Healthcare Company | $701,123 | 658 | $0 (2024) |
| Janssen Products, LP | $589,587 | 434 | $0 (2023) |
| PFIZER INC. | $257,666 | 273 | $0 (2024) |
| Theratechnologies Inc. | $96,009 | 98 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $7,079 | 7 | $0 (2021) |
| INSYS Therapeutics Inc | $3,922 | 2 | $0 (2017) |
| Janssen Scientific Affairs, LLC | $2,169 | 3 | $0 (2021) |
| GlaxoSmithKline, LLC. | $1,773 | 7 | $0 (2018) |
| Janssen Biotech, Inc. | $1,523 | 89 | $0 (2023) |
| Gilead Sciences, Inc. | $1,402 | 33 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $140,649 | 151 | ViiV Healthcare Company ($120,397) |
| 2023 | $226,705 | 276 | ViiV Healthcare Company ($133,372) |
| 2022 | $241,749 | 252 | ViiV Healthcare Company ($116,205) |
| 2021 | $166,727 | 161 | ViiV Healthcare Company ($111,430) |
| 2020 | $131,569 | 109 | ViiV Healthcare Company ($56,120) |
| 2019 | $362,482 | 314 | ViiV Healthcare Company ($146,617) |
| 2018 | $205,057 | 227 | Janssen Products, LP ($114,040) |
| 2017 | $190,379 | 175 | Janssen Products, LP ($110,726) |
All Payment Transactions
1,665 individual payment records from CMS Open Payments — Page 1 of 67
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | ViiV Healthcare Company | RUKOBIA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,300.00 | General |
| Category: HIV | ||||||
| 12/24/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $34.36 | General |
| Category: HIV | ||||||
| 12/18/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: HIV | ||||||
| 12/17/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: HIV | ||||||
| 12/11/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $31.72 | General |
| Category: HIV | ||||||
| 12/11/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $20.87 | General |
| Category: HIV | ||||||
| 12/10/2024 | ViiV Healthcare Company | — | Food and Beverage | In-kind items and services | $117.52 | General |
| 12/10/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug), DELSTRIGO | Food and Beverage | In-kind items and services | $30.46 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 12/04/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $37.03 | General |
| Category: HIV | ||||||
| 11/27/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $49.91 | General |
| Category: HIV | ||||||
| 11/26/2024 | PFIZER INC. | ABRYSVO (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,400.00 | General |
| Category: VACCINES | ||||||
| 11/26/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $48.72 | General |
| Category: HIV | ||||||
| 11/21/2024 | PFIZER INC. | ABRYSVO (Biological) | Food and Beverage | In-kind items and services | $83.05 | General |
| Category: VACCINES | ||||||
| 11/20/2024 | Theratechnologies Inc. | TROGARZO (Drug) | Food and Beverage | Cash or cash equivalent | $2,000.00 | General |
| Category: HIV | ||||||
| 11/19/2024 | PFIZER INC. | ABRYSVO (Biological) | Travel and Lodging | In-kind items and services | $154.10 | General |
| Category: VACCINES | ||||||
| 11/18/2024 | PFIZER INC. | ABRYSVO (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,375.00 | General |
| Category: VACCINES | ||||||
| 11/15/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $31.62 | General |
| Category: HIV | ||||||
| 11/09/2024 | PFIZER INC. | ABRYSVO (Biological) | Travel and Lodging | In-kind items and services | $649.72 | General |
| Category: VACCINES | ||||||
| 11/06/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $56.60 | General |
| Category: HIV | ||||||
| 10/30/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: HIV | ||||||
| 10/30/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $19.31 | General |
| 10/29/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $118.74 | General |
| Category: HIV | ||||||
| 10/29/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: HIV | ||||||
| 10/28/2024 | ViiV Healthcare Company | DOVATO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: HIV | ||||||
| 10/23/2024 | PFIZER INC. | ABRYSVO (Biological) | Travel and Lodging | In-kind items and services | $917.57 | General |
| Category: VACCINES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 11 | 25 | $7,082 | $2,230 |
| 2022 | 1 | 13 | 23 | $7,959 | $2,168 |
| 2021 | 1 | 14 | 32 | $12,418 | $2,190 |
| 2020 | 1 | 18 | 44 | $16,282 | $2,680 |
Total Patients
56
Total Services
124
Medicare Billing
$9,268
Procedure Codes
4
All Medicare Procedures & Services
4 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 11 | 25 | $7,082 | $2,230 | 31.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 13 | 23 | $7,959 | $2,168 | 27.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 14 | 32 | $12,418 | $2,190 | 17.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 18 | 44 | $16,282 | $2,680 | 16.5% |
About Dr. Elizabeth Race, MD
Dr. Elizabeth Race, MD is a Infectious Disease healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1568424596.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Elizabeth Race, MD has received a total of $1.7M in payments from pharmaceutical and medical device companies, with $140,649 received in 2024. These payments were reported across 1,665 transactions from 21 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($1.3M).
As a Medicare-enrolled provider, Race has provided services to 56 Medicare beneficiaries, totaling 124 services with total Medicare billing of $9,268. Data is available for 4 years (2020–2023), covering 4 distinct procedure/service records.
Ad
Practice Information
- Specialty Infectious Disease
- Location Dallas, TX
- Active Since 04/05/2006
- Last Updated 07/21/2016
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1568424596
Products in Payments
- DOVATO (Drug) $542,214
- SYMTUZA (Drug) $262,105
- TRUMENBA (Biological) $147,675
- PREZCOBIX (Drug) $116,129
- Symtuza (Drug) $111,862
- TROGARZO (Drug) $91,389
- RUKOBIA (Drug) $77,325
- PREVNAR - 13 (Biological) $53,103
- PREVNAR 20 (Biological) $27,281
- ABRYSVO (Biological) $25,447
- TIVICAY (Drug) $17,946
- JULUCA (Drug) $15,560
- CABENUVA (Biological) $11,712
- SYNDROS (Drug) $3,922
- PREVNAR 13 (Biological) $3,050
- EGRIFTA (Drug) $2,120
- DEFLUX (Device) $900.00
- TRIUMEQ (Drug) $770.11
- PIFELTRO (Drug) $671.67
- APRETUDE (Biological) $645.47
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Dallas
Gary Sinclair, Md, MD
Infectious Disease — Payments: $673,747
Infectious Disease $673,747
Han Schmidly
Infectious Disease — Payments: $548,373
Infectious Disease $548,373
Dr. Edward Dominguez, M.d, M.D
Infectious Disease — Payments: $309,485
Infectious Disease $309,485
Dr. Roger Bedimo, M.d, M.D
Infectious Disease — Payments: $276,484
Infectious Disease $276,484
Christopher Bettacchi, Md, MD
Infectious Disease — Payments: $198,393
Infectious Disease $198,393
Dr. Jason Gillman, Md, MD
Infectious Disease — Payments: $61,274
Infectious Disease $61,274